Expression of basic fibroblast growth factor correlates with resistance to paclitaxel in human patient tumors

Pharmaceutical Research

Volumn 23, Issue 6, 2006, Pages 1324-1331

  Gan, Yuebo ^a   Wientjes, M Guillaume ^a,b   Au, Jessie L S ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Fibroblast growth factor; Paclitaxel; Resistance

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR; GLYCOPROTEIN P; PACLITAXEL; PROTEIN BCL 2; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOINFORMATICS; BLADDER CANCER; BREAST CANCER; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG EFFECT; DRUG RESISTANCE; DRUG SENSITIVITY; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCUBATION TIME; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SOLID TUMOR; STATISTICAL ANALYSIS; TISSUE CULTURE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FEMALE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; HUMANS; MALE; OVARIAN NEOPLASMS; P-GLYCOPROTEIN; PACLITAXEL; PROGNOSIS; TISSUE CULTURE TECHNIQUES; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 33745418150     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-006-0136-6     Document Type: Article

References (55)

1. I. Ader C. Toulas F. Dalenc C. Delmas J. Bonnet E. Cohen-Jonathan G. Favre 2002 RhoB controls the 24 kDa FGF-2-induced radioresistance in HeLa cells by preventing post-mitotic cell death Oncogene 21 5998 6006
2. C. J. Powers S. W. [tmp] McLeskey A. Wellstein 2000 Fibroblast growth factors, their receptors and signaling Endocr.-Relat. Cancer 7 165 197
3. G. Szebenyi J. F. Fallon 1999 Fibroblast growth factors as multifunctional signaling factors Int. Rev. Cytol. 185 45 106
4. J. K. Dow R. W. de Vere White 2000 Fibroblast growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions Urology 55 800 806
5. S. M. Carroll C. M. Carroll R. W. Stremel S. J. Heilman J. M. Steffen G. R. Tobin J. H. Barker 2000 Vascular delay and administration of basic fibroblast growth factor augment latissimus dorsi muscle flap perfusion and function Plast. Reconstr. Surg. 105 964 971
6. G. Brill N. Vaisman G. Neufeld C. Kalcheim 1992 BHK-21-derived cell lines that produce basic fibroblast growth factor, but not parental BHK-21 cells, initiate neuronal differentiation of neural crest progenitors Development 115 1059 1069
7. G. Dini S. Funghini E. Witort L. Magnelli E. Fanti D. B. Rifkin M. Del Rosso 2002 Overexpression of the 18 kDa and 22/24 kDa FGF-2 isoforms results in differential drug resistance and amplification potential J. Cell. Physiol. 193 64 72
8. O. E. Pardo A. Arcaro G. Salerno S. Raguz J. Downward M. J. Seckl 2002 Fibroblast growth factor-2 induces translational regulation of Bcl-XL and Bcl-2 via a MEK-dependent pathway: correlation with resistance to etoposide-induced apoptosis J. Biol. Chem. 277 12040 12046
9. E. Cohen-Jonathan C. Toulas S. Monteil B. Couderc A. Maret J. J. Bard H. Prats N. Daly-Schveitzer G. Favre 1997 Radioresistance induced by the high molecular forms of the basic fibroblast growth factor is associated with an increased G2 delay and a hyperphosphorylation of p34CDC2 in HeLa cells Cancer Res. 57 1364 1370
10. J. C. Fox J. R. Shanley 1996 Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells J. Biol. Chem. 271 12578 12584
11. Z. Fuks R. S. Persaud A. Alfieri M. [tmp] McLoughlin D. Ehleiter J. L. Schwartz A. P. Seddon C. Cordon-Cardo A. Haimovitz-Friedman 1994 Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo Cancer Res. 54 2582 2590
12. L. A. Pena Z. Fuks R. N. Kolesnick 2000 Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency Cancer Res. 60 321 327
13. H. Miyake I. Hara K. Gohji K. Yoshimura S. Arakawa S. Kamidono 1998 Expression of basic fibroblast growth factor is associated with resistance to cisplatin in a human bladder cancer cell line Cancer Lett. 123 121 126
14. A. B. Coleman M. Z. Metz C. A. Donohue R. E. Schwarz S. E. Kane 2002 Chemosensitization by fibroblast growth factor-2 is not dependent upon proliferation, S-phase accumulation, or p53 status Biochem. Pharmacol. 64 1111 1123
15. P. Maloof Q. Wang H. Wang D. Stein T. N. Denny J. Yahalom E. Fenig R. Wieder 1999 Overexpression of basic fibroblast growth factor (FGF-2) downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells Breast Cancer Res. Treat. 56 153 167
16. Q. Wang P. Maloof H. Wang E. Fenig D. Stein G. Nichols T. N. Denny J. Yahalom R. Wieder 1998 Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells Exp. Cell Res. 238 177 187
17. H. Wang M. Rubin E. Fenig A. DeBlasio J. Mendelsohn J. Yahalom R. Wieder 1997 Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory G1 events Cancer Res. 57 1750 1757
18. S. A. Burchill G. Westwood 2002 Mechanism of basic fibroblast growth factor-induced cell death Apoptosis 7 5 12
19. A. B. Coleman 2003 Positive and negative regulation of cellular sensitivity to anti-cancer drugs by FGF-2 Drug Resist. Updat. 6 85 94
20. A. G. Estevez R. Radi L. Barbeito J. T. Shin J. A. Thompson 1995 Peroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors J. Neurochem. 65 1543 1550
21. K. Boelaert C. J. [tmp] McCabe L. A. Tannahill N. J. Gittoes R. L. Holder J. C. Watkinson A. R. Bradwell M. C. Sheppard J. A. Franklyn 2003 Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer J. Clin. Endocrinol. Metab. 88 2341 2347
22. T. Ruotsalainen H. Joensuu K. Mattson P. Salven 2002 High pretreatment serum concentration of basic fibroblast growth factor is a predictor of poor prognosis in small cell lung cancer Cancer Epidemiol. Biomark. Prev. 11 1492 1495
23. R. T. Poon I. O. Ng C. Lau W. C. Yu S. T. Fan J. Wong 2001 Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma Am. J. Surg. 182 298 304
24. M. Bredel I. F. Pollack J. W. Campbell R. L. Hamilton 1997 Basic fibroblast growth factor expression as a predictor of prognosis in pediatric high-grade gliomas Clin. Cancer Res. 3 2157 2164
25. M. Volm R. Koomagi J. Mattern G. Stammler 1997 Prognostic value of basic fibroblast growth factor and its receptor (FGFR-1) in patients with non-small cell lung carcinomas Eur. J. Cancer 33 691 693
26. T. Ueki T. Koji S. Tamiya P. K. Nakane M. Tsuneyoshi 1995 Expression of basic fibroblast growth factor and fibroblast growth factor receptor in advanced gastric carcinoma J. Pathol. 177 353 361
27. B. Davidson I. Goldberg W. H. Gotlieb J. Kopolovic G. Ben Baruch J. M. Nesland R. Reich 2002 The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma Mol. Cell. Endocrinol. 187 39 45
28. A. Faridi C. Rudlowski S. Biesterfeld S. Schuh W. Rath W. Schroder 2002 Long-term follow-up and prognostic significance of angiogenic basic fibroblast growth factor (bFGF) expression in patients with breast cancer Pathol. Res. Pract. 198 1 5
29. A. Obermair K. H. Taylor M. Janda J. L. Nicklin A. J. Crandon L. Perrin 2001 Primary fallopian tube carcinoma: the Queensland experience Int. J. Gynecol. Cancer 11 69 72
30. A. Obermair P. Speiser K. Reisenberger R. Ullrich K. Czerwenka A. Kaider R. Zeillinger M. Miksche 1998 Influence of intratumoral basic fibroblast growth factor concentration on survival in ovarian cancer patients Cancer Lett. 130 69 76
31. U. Eppenberger W. Kueng M. Schlaeppi J. L. Roesel C. Benz H. Mueller A. Matter M. Zuber K. Luescher M. Litschgi M. Schmitt J. A. Foekens S. Eppenberger-Castori 1998 Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients J. Clin. Oncol. 16 3129 3136
32. R. Colomer J. Aparicio S. Montero C. Guzman L. Larrodera H. Cortes-Funes 1997 Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma Br. J. Cancer 76 1215 1220
33. D. W. Visscher F. DeMattia S. Ottosen F. H. Sarkar J. D. Crissman 1995 Biologic and clinical significance of basic fibroblast growth factor immunostaining in breast carcinoma Mod. Pathol. 8 665 670
34. S. Song M. G. Wientjes Y. Gan J. L. Au 2000 Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs Proc. Natl. Acad. Sci. USA 97 8658 8663
35. S. Song M. G. Wientjes C. Walsh J. L. Au 2001 Nontoxic doses of suramin enhance activity of paclitaxel against lung metastases Cancer Res. 61 6145 6150
36. B. Yu, G. Wientjes, J. Au. bFGF as a therapeutic target for chemosensitization in colorectal cancer (Abstract). Proceedings AACR 47 (#6615) (2006).
37. Y. Wei J. L. Au 2005 Role of tumour microenvironment in chemoresistance G. G. Meadows Integration/Interaction of Oncologic Growth Springer Dordrecht, The Netherlands 285 321
38. N. Zahir V. M. Weaver 2004 Death in the third dimension: apoptosis regulation and tissue architecture Curr. Opin. Genet. Dev. 14 71 80
39. T. Furukawa T. Kubota R. M. Hoffman 1995 Clinical applications of the histoculture drug response assay Clin. Cancer Res. 1 305 311
40. T. Kubota N. Sasano O. Abe I. Nakao E. Kawamura T. Saito M. Endo K. Kimura H. Demura H. Sasano 1995 Potential of the histoculture drug-response assay to contribute to cancer patient survival Clin. Cancer Res. 1 1537 1543
41. K. T. Robbins K. M. Connors A. M. Storniolo C. Hanchett R. M. Hoffman 1994 Sponge-gel-supported histoculture drug-response assay for head and neck cancer. Correlations with clinical response to cisplatin Arch. Otolaryngol. Head Neck Surg. 120 288 292
42. Y. Gan M. G. Wientjes J. L. Au 1994 Relationship between paclitaxel activity and pathobiology of human solid tumors Clin. Cancer Res. 4 2949 2955
43. Y. Gan M. G. Wientjes D. E. Schuller J. L. Au 1994 Pharmacodynamics of taxol in human head and neck tumors Cancer Res. 56 2086 2093
44. T. M. Ludden S. L. Beal L. B. Sheiner 1994 Comparison of the Akaike Information Criterion, the Schwarz criterion and the F test as guides to model selection J. Pharmacokinet. Biopharm. 22 431 445
45. D. Li S. H. Jang J. Kim M. G. Wientjes J. L. Au 2003 Enhanced drug-induced apoptosis associated with P-glycoprotein overexpression is specific to antimicrotubule agents Pharm. Res. 20 45 50
46. D. Li J. L. Au 2001 Mdr1 transfection causes enhanced apoptosis by paclitaxel: an effect independent of drug efflux function of P-glycoprotein Pharm. Res. 18 907 913
47. R. E. Friesel T. Maciag 1995 Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction FASEB J. 9 919 925
48. R. W. Lim C. Y. Zhu B. Stringer 1995 Differential regulation of primary response gene expression in skeletal muscle cells through multiple signal transduction pathways Biochim. Biophys. Acta 1266 91 100
49. R. I. Glazer C. Rohlff 1994 Transcriptional regulation of multidrug resistance in breast cancer Breast Cancer Res. Treat. 31 263 271
50. C. A. O'Brian N. E. Ward K. R. Gravitt D. Fan 1994 The role of protein kinase C in multidrug resistance Cancer Treat. Res. 73 41 55
51. B. Galy L. Creancier C. Zanibellato A. C. Prats H. Prats 2001 Tumour suppressor p53 inhibits human fibroblast growth factor 2 expression by a post-transcriptional mechanism Oncogene 20 1669 1677
52. K. V. Chin K. Ueda I. Pastan M. M. Gottesman 1992 Modulation of activity of the promoter of the human MDR1 gene by Ras and p53 Science 255 459 462
53. K. C. Kent S. Mii E. O. Harrington J. D. Chang S. Mallette J. A. Ware 1995 Requirement for protein kinase C activation in basic fibroblast growth factor-induced human endothelial cell proliferation Circ. Res. 77 231 238
54. T. Ueba T. Nosaka J. A. Takahashi F. Shibata R. Z. Florkiewicz B. Vogelstein Y. Oda H. Kikuchi M. Hatanaka 1994 Transcriptional regulation of basic fibroblast growth factor gene by p53 in human glioblastoma and hepatocellular carcinoma cells Proc. Natl. Acad. Sci. USA 91 9009 9013
55. R. L. Zastawny R. Salvino J. Chen S. Benchimol V. Ling 1993 The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53 Oncogene 8 1529 1535